Reckitt Benckiser Group plc (LSE:RB) entered into a definitive agreement to acquire TheraPearl and Biofreeze from Performance Health, LLC for $1.1 billion on February 24, 2021. The transaction is subject to certain regulatory approvals as well as other customary closing conditions and completion is currently expected in Q2 2021. Centerview Partners UK LLP acted as exclusive financial adviser to RB on the transaction.

The Goldman Sachs Group, Inc. (NYSE:GS) and Barclays Capital Markets, LLC acted as financial advisor to Performance Health. Mark Fennell, Sandy Perl, Rachel Cantor, Josh McLane, Dan Hoppe, Aaron Lorber, Michael Wright, Kyle Gillen, Robert Zitko, Ian John, John Caruso, Paula Riedel, Marin Boney, Katie Sullivan, Mario Mancuso, Matthew Shiels, Toby Chun, Michael Schulman, Kurt Wunderlich, Thomas Wilson and Todd Herst of Kirkland & Ellis LLP acted as legal advisor to Madison Dearborn Partners and Performance Health. Davis Polk & Wardwell LLP acted as legal advisor to Reckitt Benckiser Group plc.